320 results

advamed2009
Value

Posted on 14.10.2009

John Wilkinson at AdvaMed 2009: A view on the US health reforms

A chill wind is blowing through Washington D.C. this morning and it is not just the cold front from the North blowing away the warm Autumn sun of yesterday. Yesterday, the Obama health reforms took their first step on a long and perilous road through the legislature when the Senate Finance Committee passed the preliminary […]

By John Wilkinson Former Chief Executive of Eucomed

bridge building
Access Regulation

Posted on 06.10.2009

John Brennan: Irish YES to Europe

I put it down to Irish politeness to always say “no” first when asked if we want something and to follow up with a “yes” when asked the second time. “Will you have a cup of Lisbon tea?Oh no thank you, I’ve had quite enough already.Are you sure? I’ve just made some and I can […]

By John Brennan Director Regulations and Industrial Policy

facts-figures
Value

Posted on 18.08.2009

Facts and figures, not political rhetoric, as a basis for healthcare reform

Returning to the daily routine after a long, and hot, summer break is always characterised by mixed feelings. Part wishes the languorous morning routines to carry on whilst other forces bring a refreshed mind optimistic about the challenges ahead. This morning’s bright and early start in Brussels was illuminated by two articles in the Financial […]

By John Wilkinson Former Chief Executive of Eucomed

bank
Business

Posted on 22.07.2009

Credit default swaps and the real world

The arcane world of credit default swaps may seem a very curious subject to stimulate the mind of a life-long medical technology man. My thoughts turned to these strange and questionable instruments, which appear to be one of the roots of the financial crisis, during a week when they were seldom far from the front […]

By John Wilkinson Former Chief Executive of Eucomed

problemorsolution
Value

Posted on 16.07.2009

Are we the problem or the solution?

Browsing the news pages of the web I came across an article in a journal that I am not familiar with from the USA, the grandly titled U.S. News & World Report. The report headed off on a familiar and now even more fashionable track of squarely identifying our industry as the villains of the […]

By John Wilkinson Former Chief Executive of Eucomed

develop-tree
Global

Posted on 08.07.2009

Creating a coordinated global platform to safeguard health development systems in the future

Talking about the role of the EU in the developing world EC Director General for Development Stefano Manservisi described the new approach to health development policy on a global level: “From donorship to partnership”. He explained that access to medicine needs to be viewed as not only provision of medicines but rather the ability to […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

innovate2
Regulation

Posted on 25.06.2009

Achieving health improvements inside and outside the boardroom

A crowded room at the offices of the European Policy Center yesterday afternoon. The topic of the day is “The future of medical devices in Europe”. The distinguished panel includes Josée Hansen, Pharm. D, project leader, Priority Medical Devices/ EHT, WHO-Geneva . Ms Hansen elaborated on the project’s approach, scope and objectives. In a nutshell, […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

competitive
Value

Posted on 19.06.2009

Europe needs a highly competitive single market if it is to sustain our quality of life

Warm summer sunshine bathed the triumphal arch of the Parc du Cinquantenaire as colleague John Brennan and I walked down the tree-lined Avenue de  Tervuren to attend sister organisation COCIR’s 50th birthday party. Highlight of a wonderfully sociable evening amongst a veritable “who’s who” of the medical technology industry in Brussels was an impassioned speech […]

By John Wilkinson Former Chief Executive of Eucomed

hc-inno
Business

Posted on 29.05.2009

2009 Hauptstadtkongress debates affordability of innovation for the German healthcare system

Is innovation still affordable with increasingly strained healthcare budgets? How can medical innovations continued to be financed? Panelist of the round table of distinguished speakers Member of the European Parliament Jorgo Chatzimarkakis made a statement which nicely complements the study released by AdvaMed only 2 days ago. He said that innovation does not increase costs […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed